We are live on ! Find out more
ACOR

Acorda Therapeutics
ACOR

Delisted

ACOR was delisted on the 11th of April, 2024.

Back to rankings

170 hedge funds and large institutions have $1.51B invested in Acorda Therapeutics in 2015 Q2 according to their latest regulatory filings, with 12 funds opening new positions, 65 increasing their positions, 61 reducing their positions, and 32 closing their positions.

New
Increased
Maintained
Reduced
Closed

7% more repeat investments, than reductions

Existing positions increased: 65 | Existing positions reduced: 61

0% more call options, than puts

Call options by funds: $2.5M | Put options by funds: $2.5M

1% less capital invested

Capital invested by funds: $1.53B → $1.51B (-$20.8M)

11% less funds holding

Funds holding: 190 → 170 (-20)

63% less first-time investments, than exits

New positions opened: 12 | Existing positions closed: 32

100% less funds holding in top 10

Funds holding in top 10: 1 → 0 (-1)

Holders
170
Holders Change
-20
Holders Change %
-10.53%
% of All Funds
4.58%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
12
Increased
65
Reduced
61
Closed
32
Calls
$2.5M
Puts
$2.5M
Net Calls
+$1K
Net Calls Change
-$1.77M

Top Buyers

Rank Fund Capital Flow
1
UBS AM
UBS AM
Illinois
+$27.2M
2
PHS
PFM Health Sciences
California
+$11.3M
3
State Street
State Street
Massachusetts
+$6.74M
4
AC
Armistice Capital
New York
+$5.99M
5
SFM
Sphera Funds Management
Israel
+$4.83M

Top Sellers

Rank Fund Capital Flow
1
Morgan Stanley
Morgan Stanley
New York
-$15.3M
2
Millennium Management
Millennium Management
New York
-$14M
3
AG
Artal Group
Luxembourg
-$8.32M
4
OIM
Oracle Investment Management
Connecticut
-$7.37M
5
HCM
Highbridge Capital Management
New York
-$6.59M
Name Holding Trade Value Shares
Change 		Change in
Stake
Stifel Financial
76
Stifel Financial
Missouri
$2.31M +$220K +57 +11%
DC
77
Deere & Company
Illinois
$2.26M +$88.8K +23 +4%
RFC
78
Russell Frank Company
Washington
$2.24M +$521K +135 +32%
MOACM
79
Mutual of America Capital Management
New York
$2.23M +$11.6K +3 +0.5%
Public Sector Pension Investment Board (PSP Investments)
80
Public Sector Pension Investment Board (PSP Investments)
Quebec, Canada
$2.2M -$464K -120 -18%
QI
81
QS Investors
New York
$2.17M – – –
Ohio Public Employees Retirement System (OPERS)
82
Ohio Public Employees Retirement System (OPERS)
Ohio
$1.88M – – –
PC
83
Polar Capital
United Kingdom
$1.78M +$1.47M +381 +595%
AQR Capital Management
84
AQR Capital Management
Connecticut
$1.78M -$1.61M -416 -48%
Swiss National Bank
85
Swiss National Bank
Switzerland
$1.76M +$259K +67 +18%
RhumbLine Advisers
86
RhumbLine Advisers
Massachusetts
$1.76M +$57.9K +15 +4%
TC
87
TFS Capital
Pennsylvania
$1.75M -$255K -66 -13%
Jacobs Levy Equity Management
88
Jacobs Levy Equity Management
New Jersey
$1.74M -$491K -127 -23%
New York State Teachers Retirement System (NYSTRS)
89
New York State Teachers Retirement System (NYSTRS)
New York
$1.65M – – –
State Board of Administration of Florida Retirement System
90
State Board of Administration of Florida Retirement System
Florida
$1.5M +$104K +27 +8%
NFA
91
Nationwide Fund Advisors
Ohio
$1.44M -$425K -110 -23%
AA
92
ALPS Advisors
Colorado
$1.42M +$688K +178 +101%
VRS
93
Virginia Retirement Systems
Virginia
$1.37M +$769K +199 +138%
ProShare Advisors
94
ProShare Advisors
Maryland
$1.34M -$100K -26 -7%
TPSF
95
Texas Permanent School Fund
Texas
$1.21M -$65.7K -17 -5%
SEI Investments
96
SEI Investments
Pennsylvania
$1.2M +$34.8K +9 +3%
GT
97
Glenmede Trust
Pennsylvania
$1.13M – – –
State of Tennessee, Department of Treasury
98
State of Tennessee, Department of Treasury
Tennessee
$1.11M +$23.2K +6 +2%
CAM
99
ClariVest Asset Management
California
$1.09M -$3.86K -1 -0.4%
WT
100
Whittier Trust
California
$1.09M – – –
2 3
4
5 6

ACOR Hedge Fund Activity: Q2 2015 in Review

170 of the 3,711 institutional investors tracked by Wall St. Rank reported a position in Acorda Therapeutics (ACOR) for Q2 2015, worth a combined $1.51B — down 1.4% from $1.53B a quarter earlier.

Sellers outnumbered buyers: 32 funds closed out of ACOR and 12 opened new positions — a net loss of 20 holders — while 61 trimmed existing stakes and 65 added.

The largest buyer was UBS AM, adding an estimated $27.2M. The largest seller was Morgan Stanley, cutting an estimated $15.3M.

  • 170 institutional investors held Acorda Therapeutics (ACOR) as of Q2 2015, down from 190 in Q1 2015.
  • Funds reported $1.51B of Acorda Therapeutics stock for Q2 2015, down 1.4% quarter-over-quarter.
  • 12 funds opened new Acorda Therapeutics positions in Q2 2015 and 32 closed out, a net change of -20 holders.
  • The largest Acorda Therapeutics buyer in Q2 2015 was UBS AM, an estimated $27.2M added.
  • The largest Acorda Therapeutics seller in Q2 2015 was Morgan Stanley, an estimated $15.3M sold.

Based on aggregated 13F filings for Q2 2015.